Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of donepezil, a pharmaceutical acetylcholinesterase inhibitor, and Tianzhi granule, a traditional Chinese medicine (TCM) herbal formulation. Donepezil increases acetylcholine levels in the brain by inhibiting its breakdown, thereby improving cognitive function. Tianzhi granule contains multiple herbs (including Gastrodiae Rhizoma and Uncariae Ramulus Cum Uncis) and is used in China for vascular dementia; it is believed to exert neuroprotective effects through anti-inflammatory, antioxidant, antithrombotic actions and modulation of neurotrophic factors. The combination has been studied for symptomatic benefit in mild to moderate vascular dementia[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on donepezil + Tianzhi granule.